Pfizer

According to fact-checkers and health practitioners, Pfizer is not developing an ivermectin version to tr

The findings, which were published in the journal Immunity, may explain why individuals who were vaccinat

The US will allocate COVID-19 vaccine doses to low and lower-middle-income nations around the world, work

COVID-19 Vaccines are in limited supply globally, and companies have their own priorities, game plans, an

Manish Sisodia said the US has approved all three of Pfizer, Moderna, and Johnson in December 2020 but In

In order to respond to increased global demand, we plan to manufacture two billion doses of our COVID-19

US launches Phase 3 trial of 2 new antibody treatments for hospitalized COVID-19 patients combined with e